Acting as a specific inhibitor of AKR1C1, we found ALA selectively inhibited the activity of AKR1C1 and inhibited the growth of NSCLC cells both in vitro and in vivo. This evidence concerns the gene AKR1C1 and non-small cell lung carcinoma.